Two drugs are better than one to start T2DM therapy

Nature Reviews Endocrinology, Published online: 08 November 2019; doi:10.1038/s41574-019-0294-3Early and intensive glycaemic control protects patients with type 2 diabetes mellitus (T2DM) from the development of late cardiovascular complications. The authors of the VERIFY trial now show that a more durable attainment of HbA1c 

Source: Nature Reviews Endocrinology - November 7, 2019 Category: Endocrinology Authors: Francesco Prattichizzo Lucia La Sala Antonio Ceriello Source Type: research